WCVD9 Delegate E-Magazine and Guide by thewebinarvet

THE 9TH WORLD CONGRESS OF VETERINARY DERMATOLOGY Event E-Magazine and Guide

#WCVD9

WCVD-9.COM

FOREWORD

STNETNOC FO ELBAT #WCVD9

Mandy Burrows - WCVD9 President

Anthony Chadwick - The Webinar Vet CEO

David Lloyd - WCVD Committee

THE WCVD9 PLATFORM Accessing the event

The WCVD9 digital venue

The lobby

The exhibition hall

Navigating the booths

The poster room

The menu

The auditorium

Our top picks from the program

Content from our event sponsors

Our speakers

The booths in the exhibition hall

Presentation reviews with David Grant

Other news and upcoming CE events

WCVD-9.COM

Foreword from WCVD9 President

MANDY BURROWS

My name is Mandy Burrows, and I am a veterinary dermatologist from Western Australia and president of the World Congress nine, that was to be held in Sydney, before the global pandemic changed our plans. Despite the fact that we cannot welcome you to Australia, I'm delighted to invite you to share the general practice, and advanced clinical continuing education program from WCVD9, which is now available online. The general practice program, encompasses a variety of topics, specifically selected to be of relevance to veterinarians working in small animal practice. It will be delivered through a series of webinars, by the global experts in veterinary dermatology, and will be translated into four languages, Japanese, Mandarin, Spanish and Portuguese. Our clinical advanced program is relevant to those veterinarians with a special interest in dermatology, and dermatologists. This really is a program not to be missed. You'll be able to update your knowledge about a wide range of skin diseases that you see every day in your practice, while enjoying the convenience of being able to access the information to fit in with your schedule over the next six months. This really is the most prestigious international veterinary dermatology event to be delivered for the next four years. The content is expert, precise practical up to date, well presented and represents the collective experience of the best the world can offer this unique opportunity really should not be missed.

Thank you for joining us!

Mandy Burrows

#WCVD9

WCVD-9.COM

Foreword from The Webinar Vet Founder and CEO

ANTHONY CHADWICK BVSc Cert VD MRCVS

I've been present at every World Congress of Veterinary Dermatology since 1996 and I was looking forward to a trip down under and then the world changed! Who knows what the new normal will be but my team and I are determined to give you the best experience possible at WCVD9's online version. The programme is pretty much the same. Peter Hill and the committee have put an amazing set of lecture streams together to appeal to every type of vet or nurse/technician. My team are here to help navigate you through the unfamiliar waters of a virtual congress - we've been running our own Virtual Congress since 2013! If you are struggling to find what you want, please feel free to phone, email or Live Chat. Just remember if we don't get back to you immediately that we are based in the UK but we will be extending our work hours. We are here to serve you!

Enjoy! Anthony Chadwick

WCVD-9.COM

Introduction on behalf of the WCVD9 committee

DAVID LLOYD

WCVD9 WELCOMES YOU TO A FEAST OF VETERINARY DERMATOLOGY Four years ago, the WCVD9 organising committee began to set up the 9th World Congress of Veterinary Dermatology, which starts this week. It was planned to take place in the elegant new congress centre in Darling Harbour (figure 1), within the magnificent Sydney Harbour environment (figure 2), and veterinarians throughout the world were looking forward to presentation of the best in veterinary dermatology combined with an opportunity to experience the unique Australian environment. Sadly, the Covid-19 pandemic prevented this. The committee was determined not to cancel the conference and decided to deliver it online. Feasibility studies and planning for the online conference began in May 2020, just five months ago and, since then, an organisational whirlwind has been in progress to ensure delivery of as much as possible of the original programme ensure truly global availability in cooperation with The Webinar Vet.

Figure 1: The Sydney Convention and Exhibition Centre on the Darling Harbour waterfront

Figure 2: Sydney Harbour Bridge and the Opera House

We already have more delegates registered from a wider range of veterinary practices around the world than ever before - more than 70 different countries, and registration numbers continue to increase.

#WCVD9

WCVD-9.COM

It is exciting to see involvement from countries in Asia and in Africa that have not been represented in the past. High levels of involvement have been promoted by the three price levels, designed to ensure that cost is not a problem: 1) the full programme, with its cutting-edge scientific and clinical programme, 2) the comprehensive clinical programme aimed at veterinarians with a special interest in dermatology, and 3) the general practice clinical programme providing essential knowledge required on a daily basis for practices and hospitals.

Figure 3: The Hugo Schindelka Medal.

The award consists of a medal, and a sum of money. It is the premier award in our discipline and represents recognition of excellence in scholarship and publication in veterinary dermatology. The recipient will then deliver a special lecture, and this promises to be an exceptional presentation.

Availability of this general veterinary practice programme has now been expanded by provision of video lectures and notes in four additional languages: Chinese, Japanese, Portuguese and Spanish. Furthermore, the Chinese programme is available from a server in China to ensure that streaming of lectures will progress as smoothly as possible.

Hugo Schindelka was a professor at the veterinary school in Vienna (Austria) and published, in 1903, the first detailed book on Skin Diseases of Domestic Animals, This was illustrated by clinical pictures drawn by the author. I feel sure that Prof Schindelka would be very pleased to see how the discipline which he initiated has progressed in the 115 years since publication of his book.

The Congress begins on 21st of October with the Company Symposia, presented by our nine principal sponsors and covering an impressive variety of topics; each symposium lasting three hours. The main programme begins on October 22, with an opening ceremony which will have a special Australian flavour. All of the conference presentations will then be available online from the WCVD9 virtual online Congress Centre, together with the poster display and the interactive virtual commercial exhibition. Availability will continue for six months â&#x20AC;&#x201C; until 20th of April 2021 â&#x20AC;&#x201C; allowing ample time to watch all of the video programmes and study the associated notes.

It is now 30 years since the 1st World Congress of Veterinary Dermatology was held in Dijon, France in September 1989. This was also a great adventure for the organising committee. There was no precedent for a world congress in any specialty of veterinary medicine, so dermatology set a new standard. The Dijon committee had to develop new ideas with very limited funding. Even so, the congress was very successful. It seems likely that WCVD9 will also set new standards and establish precedents for delivery of costeffective education in specialty veterinary medicine on a global basis.

The opening ceremony will include announcement of the recipient of the Hugo Schindelka Award of the World Association for Veterinary Dermatology (figure 3. The Hugo Schindelka Medal).

#WCVD9

David Lloyd 6

WCVD-9.COM

ACCESSING THE EVENT

Go to watch.wcvd-9.com Enter your login details (you will have received these via email) You will be taken to the entry to our WCVD9 digital venue

#WCVD9

WCVD-9.COM

THE WCVD9 DIGITAL VENUE

We are incredibly excited to show you the digital venue for WCVD9 - there's so much to explore! Once you have logged in, you will have access to the the digital venue and can view the exhibition, auditorium and posters.

In the auditorium, you will be able to access all of the webinar content that is available with your WCVD9 ticket.

In the exhibition, you can access all of the content from our sponsors and have a browse of the different exciting exhibition stands.

In the posters room, you can have a look at all of the different posters and download them if you wish.

Let's get started! #WCVD9

WCVD-9.COM

The Lobby In the lobby you will find a number of different ways to navigate around the WCVD9 venue. You can click on any of the logos of the primary sponsors on the lobby walls to be taken directly to their booth in the exhibition centre. You can also click on 'Exhibition' to go straight to the exhibition hall, or 'Auditorium' to go to the auditorium where you can access your webinars. You can also access the posters room from the lobby.

Click on your chosen room to enter

#WCVD9

WCVD-9.COM

The Exhibition Hall Once you have entered the exhibition hall, you will get a full 360 degree view of all of the booths. To navigate around, simply click the blue arrows you see on the floor. To enter a booth, click on the blue arrow that points into your chosen booth.

Use the blue arrows to navigate round the exhibition hall

#WCVD9

Click the arrow pointing into your chosen booth to enter

WCVD-9.COM

Navigating the Booths Within the booths themselves, there's a whole load of different things to interact with! There are videos, downloadable content, Q&A sessions, photo booths, games, quizzes and more! It's a very interactive experience.

Click and drag to navigate around each booth and explore the content

#WCVD9

WCVD-9.COM

The Poster Room At WCVD9 you can expect to see hundreds of posters from various experts, with all the latest research. The posters are organised into alphabetical order in the different pods. Once you have entered the pod you can click through the different posters - you will see the name of the poster and the author. You can drag your mouse to navigate around. To make things easier, you can also click 'LIST' in the bottom right corner and a list by author surname will appear. Once you've found a poster that you like you can click on it and read it within the screen, maximise it to make it full screen, or download it if you wish. Click 'LIST' to see the list view of the different posters

#WCVD9

WCVD-9.COM

The Menu Everywhere that you go within the venue you will see the 'Menu' button in the top left corner of your screen. Once clicked, you have the option to navigate to anywhere within the event venue. You can click on any of the different booths, logos, auditorium or anywhere else and be taken there instantly.

Click anywhere on the menu to be taken to your chosen destination

#WCVD9

WCVD-9.COM

The Auditorium How to Access Your Webinars

Once you have entered the WCVD9 auditorium, you will be able to access all of the content that is relevant to your ticket. Simply click on the 'Watch Here' button and it will bring up all of the relevant content for you to watch. You can also use the search function to find specific content easily.

Browse through all of the content you have access to and search easily for whatever you would like to watch

#WCVD9

WCVD-9.COM

TOP PICKS FROM THE PROGRAM What are we looking forward to in the WCVD9 program?

GP Dermatology CE

Dermatology in General Practice

Ralf Mueller

Wayne Rosenkrantz

DIAGNOSTIC APPROACH TO THE ITCHY DOG WITHOUT OVER-SERVICING

CANINE ATOPIC DERMATITIS – WHERE DO THE NEW TREATMENTS FIT IN?

Doug DeBoer

Craig Griffin

STAPH PYODERMA – AN UPDATE ON DIAGNOSIS AND MANAGEMENT

MANAGEMENT OF ACUTE OTITIS EXTERNA

Peter Hill

Catherine Outerbridge

CLINICAL SIGNS AND DIAGNOSIS OF CANINE ATOPIC DERMATITIS

HYPOTHYROIDISM – WHAT SHOULD WE BE DOING?

Advanced CE

Advanced Dermatology for Clinical Practice

David Robson

Doug DeBoer

MANAGEMENT OF RESISTANT STAPHYLOCOCCAL INFECTIONS IN DOGS – THE AUSTRALIAN PERSPECTIVE

ALLERGY TESTING – IS IT STILL WORTH DOING?

Rosanna Marsella

Peter Hill

MANAGEMENT OF BARRIER FUNCTION – DOES IT HELP?

A PRACTITIONER’S APPROACH TO IMMUNEMEDIATED SKIN DISEASES

Elizabeth Mauldin

Mike Shipstone

GENERAL APPROACH TO SCALING DISORDERS

LASERS IN VETERINARY DERMATOLOGY

OUR TOP PICKS

WCVD-9.COM

State of the Art CE

Scientific Advances in Dermatology (SOA)

Dedee Murrell

Rosanna Marsella

STATE OF THE ART WHAT’S NEW IN AUTOIMMUNE BLISTERING DISEASES

SUPPORTING REVIEW ADVANCES IN OUR UNDERSTANDING OF CANINE ATOPIC DERMATITIS

Susan Prescott

Darren Trott

STATE OF THE ART THE PANDEMIC OF INFLAMMATION

STATE OF THE ART ANTIMICROBIAL RESISTANCE AND NOVEL THERAPIES

Tetsuro Kobayashi

Stephen Jane

SUPPORTING REVIEW IMMUNE RESPONSES TO THE MICROBIOME

STATE OF THE ART GENETICS OF BARRIER FUNCTION

Species CE

Feline Dermatology Equine Dermatology

Mandy Burrows

Wildlife & Exotics

ALLERGY TESTING IN CATS – IS IT WORTH IT? Wayne Rosenkrantz

Stephen White

MANAGEMENT OF THE ATOPIC CAT – HAVE WE MOVED AWAY FROM PREDNISOLONE?

SKIN DISEASES IN DONKEYS

Danny Scott

Scott Carver

APPROACH TO THE PRURITIC HORSE

SARCOPTIC MANGE IN WOMBATS AND KOALAS

OUR TOP PICKS

WCVD-9.COM

CONTENT FROM OUR SPONSORS

OUR TOP PICKS

WCVD-9.COM

Would you like to know more about

owners expectations â&#x20AC;&#x201C; new trends in dermatology? Dr. Natalie Marks DVM, CVJ

Dr. Chiara Noli DVM, Dip ECVD

Societal trends in pet ownership

Impact on the management of atopic dermatitis in dogs

Buy your pass & come listen to our Ceva Symposium

Visit our stand, Discover our products, Play & reach the top score!

Pr. Marie-Christine Cadiergues DVM, PhD, Dip ECVD What about seborrheic disorders in dogs?

Catch the new safety wave

OPTIMUM PERFORMANCE: Simultaneous threefold action

YT RI U PH FROM

CTIO N NCA

S AFE S

on the 3 skin barriers for optimum skin barrier ecosystem protection.

WITH

OPTIMUM SIMPLICITY: Only the essential for optimum safety

(no soap, sulphate, paraben, colourant, nanoparticles - adjusted pH and hypoallergenic fragrance).

OPTIMUM TOLERANCE: All formulas tested in acute and field conditions for optimum serenity.

Product labels and claims can differ between countries. This document is based on the USA labeling. Please contact your Zoetis representative in your country for your country specific information.

WHEN PROVIDING ALLERGIC ITCH RELIEF, GIVE

An in-office injectable that lasts 4-8 weeks,1,2 CYTOPOINT ensures that the power to deliver relief is in your hands

Work together with pet owners toward compliance with a CYTOPLAN and CYTOPOINTMENTS LEARN MORE AT CYTOPOINT.COM

INDICATIONS: CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis. References: 1. Data on file, Study Report No. C863R-US-12-018, Zoetis Inc. 2. Data on file, Study Report No. C166R-US-17-180, Zoetis Inc.

Product labels and claims can differ between countries. This document is based on the USA labeling. Please contact your Zoetis representative in your country for your country specific information.

The road to itch relief felt like a long one, until APOQUEL Trusted for over 6 years, APOQUEL® (oclacitinib tablet) has been prescribed to more than 8 million dogs in need of fast and effective allergic itch relief.1-4

#1 in veterinarian and pet owner satisfaction5,6* Savings are now available for your clients through Zoetis Petcare Rewards! Learn more at APOQUEL.com INDICATIONS

Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. IMPORTANT SAFETY INFORMATION Do not use APOQUEL® (oclacitinib tablet) in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines. See accompanying Brief Summary of Prescribing Information *Based on survey data from veterinarians (n=250) and pet owners (n=150). References: 1. Data on file, 2014-2018 APOQUEL Brand Health, 2019, Zoetis Inc. 2. Data on file, Unique Patient Count from Launch, 2020, Zoetis Inc. 3. Gadeyne C, Little P, King VL, et al. Efficacy of oclacitinib (APOQUEL®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol. 2014;25(6):512-e86. doi:10.1111/vde.12166. 4. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114. doi:10.1111/vde.12047. 5. Data on file, APOQUEL/CYTOPOINT Vet Tracker Wave 11, 2018, Zoetis Inc. 6. Data on file, APOQUEL/CYTOPOINT Pet Tracker Wave 6, 2019, Zoetis Inc.

2 best-in-class options for allergic itch relief: All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2020 Zoetis Services LLC. All rights reserved. APQ-01033

Product labels and claims can differ between countries. This document is based on the USA labeling. Please contact your Zoetis representative in your country for your country specific information.

Brief Summary of Prescribing Information For oral use in dogs only Caution: Federal (USA) Law restricts this drug to use by or on the order of a licensed veterinarian. Indications: Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Dosage and Administration: The dose of APOQUEL (oclacitinib maleate) tablets is 0.18 to 0.27 mg oclacitinib/lb (0.4 to 0.6 mg oclacitinib/kg) body weight, administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy. APOQUEL may be administered with or without food. Dosing Chart Weight Range Weight Range Number of Tablets to be Administered (in lb) (in Kg) Low High Low High 3.6 mg 5.4 mg 16 mg Tablets Tablets Tablets 6.6 9.9 3.0 4.4 0.5 10.0 14.9 4.5 5.9 0.5 15.0 19.9 6.0 8.9 1 20.0 29.9 9.0 13.4 1 30.0 44.9 13.5 19.9 0.5 45.0 59.9 20.0 26.9 2 60.0 89.9 27.0 39.9 1 90.0 129.9 40.0 54.9 1.5 130.0 175.9 55.0 80.0 2 Warnings: APOQUEL is not for use in dogs less than 12 months of age (see Animal Safety). APOQUEL is not for use in dogs with serious infections. APOQUEL may increase susceptibility to infection, including demodicosis, and exacerbate neoplastic conditions (see Adverse Reactions and Animal Safety). Human Warnings: This product is not for human use. Keep this and all drugs out of reach of children. For use in dogs only. Wash hands immediately after handling the tablets. In case of accidental eye contact, flush immediately with water or saline for at least 15 minutes and then seek medical attention. In case of accidental ingestion, seek medical attention immediately. Precautions: APOQUEL is not for use in breeding dogs, or pregnant or lactating bitches. The use of APOQUEL has not been evaluated in combination with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents. Dogs receiving APOQUEL should be monitored for the development of infections, including demodicosis, and neoplasia. Adverse Reactions: Control of Atopic Dermatitis In a masked field study to assess the effectiveness and safety of oclacitinib for the control of atopic dermatitis in dogs, 152 dogs treated with APOQUEL and 147 dogs treated with placebo (vehicle control) were evaluated for safety. The majority of dogs in the placebo group withdrew from the 112-day study by Day 16. Adverse reactions reported (and percent of dogs affected) during Days 0-16 included diarrhea (4.6% APOQUEL, 3.4% placebo), vomiting (3.9% APOQUEL, 4.1% placebo), anorexia (2.6% APOQUEL, 0% placebo), new cutaneous or subcutaneous lump (2.6% APOQUEL, 2.7% placebo), and lethargy (2.0% APOQUEL, 1.4% placebo). In most cases, diarrhea, vomiting, anorexia, and lethargy spontaneously resolved with continued dosing. Dogs on APOQUEL had decreased leukocytes (neutrophil, eosinophil, and monocyte counts) and serum globulin, and increased cholesterol and lipase compared to the placebo group but group means remained within the normal range. Mean lymphocyte counts were transiently increased at Day 14 in the APOQUEL group. Dogs that withdrew from the masked field study could enter an unmasked study where all dogs received APOQUEL. Between the masked and unmasked study, 283 dogs received at least one dose of APOQUEL. Of these 283 dogs, two dogs were withdrawn from study due to suspected treatment-related adverse reactions: one dog that had an intense flare-up of dermatitis and severe secondary pyoderma after 19 days of APOQUEL administration, and one dog that developed generalized demodicosis after 28 days of APOQUEL administration. Two other dogs on APOQUEL were withdrawn from study due to suspected or confirmed malignant neoplasia and subsequently euthanized, including one dog that developed signs associated with a heart base mass after 21 days of APOQUEL administration, and one dog that developed a Grade III mast cell tumor after 60 days of APOQUEL administration. One of the 147 dogs in the placebo group developed a Grade I mast cell tumor and was withdrawn from the masked study. Additional dogs receiving APOQUEL were hospitalized for diagnosis and treatment of pneumonia (one dog), transient bloody vomiting and stool (one dog), and cystitis with urolithiasis (one dog).

In the 283 dogs that received APOQUEL, the following additional clinical signs were reported after beginning APOQUEL (percentage of dogs with at least one report of the clinical sign as a non-pre-existing finding): pyoderma (12.0%), non-specified dermal lumps (12.0%), otitis (9.9%), vomiting (9.2%), diarrhea (6.0%), histiocytoma (3.9%), cystitis (3.5%), anorexia (3.2%), lethargy (2.8%), yeast skin infections (2.5%), pododermatitis (2.5%), lipoma (2.1%), polydipsia (1.4%), lymphadenopathy (1.1%), nausea (1.1%), increased appetite (1.1%), aggression (1.1%), and weight loss (0.7). Control of Pruritus Associated with Allergic Dermatitis In a masked field study to assess the effectiveness and safety of oclacitinib for the control of pruritus associated with allergic dermatitis in dogs, 216 dogs treated with APOQUEL and 220 dogs treated with placebo (vehicle control) were evaluated for safety. During the 30-day study, there were no fatalities and no adverse reactions requiring hospital care. Adverse reactions reported (and percent of dogs affected) during Days 0-7 included diarrhea (2.3% APOQUEL, 0.9% placebo), vomiting (2.3% APOQUEL, 1.8% placebo), lethargy (1.8% APOQUEL, 1.4% placebo), anorexia (1.4% APOQUEL, 0% placebo), and polydipsia (1.4% APOQUEL, 0% placebo). In most of these cases, signs spontaneously resolved with continued dosing. Five APOQUEL group dogs were withdrawn from study because of: darkening areas of skin and fur (1 dog); diarrhea (1 dog); fever, lethargy and cystitis (1 dog); an inflamed footpad and vomiting (1 dog); and diarrhea, vomiting, and lethargy (1 dog). Dogs in the APOQUEL group had a slight decrease in mean white blood cell counts (neutrophil, eosinophil, and monocyte counts) that remained within the normal reference range. Mean lymphocyte count for dogs in the APOQUEL group increased at Day 7, but returned to pretreatment levels by study end without a break in APOQUEL administration. Serum cholesterol increased in 25% of APOQUEL group dogs, but mean cholesterol remained within the reference range. Continuation Field Study After completing APOQUEL field studies, 239 dogs enrolled in an unmasked (no placebo control), continuation therapy study receiving APOQUEL for an unrestricted period of time. Mean time on this study was 372 days (range 1 to 610 days). Of these 239 dogs, one dog developed demodicosis following 273 days of APOQUEL administration. One dog developed dermal pigmented viral plaques following 266 days of APOQUEL administration. One dog developed a moderately severe bronchopneumonia after 272 days of APOQUEL administration; this infection resolved with antimicrobial treatment and temporary discontinuation of APOQUEL. One dog was euthanized after developing abdominal ascites and pleural effusion of unknown etiology after 450 days of APOQUEL administration. Six dogs were euthanized because of suspected malignant neoplasms: including thoracic metastatic, abdominal metastatic, splenic, frontal sinus, and intracranial neoplasms, and transitional cell carcinoma after 17, 120, 175, 49, 141, and 286 days of APOQUEL administration, respectively. Two dogs each developed a Grade II mast cell tumor after 52 and 91 days of APOQUEL administration, respectively. One dog developed low grade B-cell lymphoma after 392 days of APOQUEL administration. Two dogs each developed an apocrine gland adenocarcinoma (one dermal, one anal sac) after approximately 210 and 320 days of APOQUEL administration, respectively. One dog developed a low grade oral spindle cell sarcoma after 320 days of APOQUEL administration. To report suspected adverse events, for technical assistance or to obtain a copy of the MSDS, contact Zoetis Inc. at 1-888-963-8471 or www.zoetis.com. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/AnimalVeterinary/SafetyHealth. Storage Conditions: APOQUEL should be stored at controlled room temperature between 20° to 25°C (68° to 77°F) with excursions between 15° to 40°C (59° to 104°F). How Supplied: APOQUEL tablets contain 3.6 mg, 5.4 mg, or 16 mg of oclacitinib as oclacitinib maleate per tablet. Each strength tablets are packaged in 20 and 100 count bottles. Each tablet is scored and marked with AQ and either an S, M, or L that correspond to the different tablet strengths on both sides. NADA #141-345, Approved by FDA Made in Italy

Distributed by: Zoetis Inc. Kalamazoo, MI 49007 February 2013

428007800A&P

FOOD + ENVIRONMENTAL ALLERGIES

LET’S MAKE ITCHING ANCIENT HISTORY Hill’s Prescription Diet Derm Complete is our masterpiece. The only nutrition for both food and environmental allergies. As part of a multimodal treatment, Derm Complete addresses two primary causes of itching with:

Novel protein that avoids 96% of food allergies1

A breakthrough formula with bioactives and phytonutrients to help manage a dog’s response to environmental allergens

A STEP AHEAD FOR THEIR BEST LIFE Mueller RS, Olivry T, Prélaud P. Critically appraised topic on adverse food reactions of companion animals (2): common food allergen sources in dogs and cats. BMC Vet Res. 2016;12:9. The Hill’s Transforming Lives logo, the Hill’s Prescription Diet logo, the S+OX SHIELD logo, Hill’s, Prescription Diet, and Derm Complete are trademarks of Hill’s Pet Nutrition, Inc. 1

Visit our booth to learn more and watch a replay of the Hill’s Symposium

LET’S MAKE

ITCHING ANCIENT HISTORY Hill’s Virtual Symposium 9th World Congress of Veterinary Dermatology October 21, 2020 Canine atopic dermatitis (CAD) is a common and chronic allergic skin disease that often requires multimodal treatment. Nutrition can play an important role in disease management. Join us for this Hill’s Virtual Symposium, where you’ll hear about:

The latest research findings and nutritional management options for CAD

2 Excellent tips on client communication for multimodal treatment 3 The most up-to-date information on nutritional management of atopic disease in people

Find Out More

The Hill’s Transforming Lives logo, and Hill’s are trademarks owned by Hill’s Pet Nutrition, Inc.

ARE YOU INTERESTED IN THIS MAGAZINE?

Find it on our stand and discover the other issues

We look forward to seeing you!

Company Online on Oct. 21, 2020 Available on demand until April 2021 VIEW HERE

Kee p t h e cat , st re n gt h e n the bond:

A tra nsfo r mat ional a p p roac h to managing

F e l d 1 , t h e m aj or cat al lergen

Speakers:

Dr. Pete Smith

Allergist and Professor of Clinical Medicine, Griffith University Queensland, Australia

Dr. Michael Lappin

Professor in Small Animal Clinical Veterinary Medicine, Colorado State University Fort Collins, USA

Dr. Ebenezer Satyaraj

Director of Molecular Nutrition, NestlĂŠ Research Center â&#x20AC;&#x201C; Petcare St. Louis, USA

PurinaInstitute.com

Visit the Elanco Otitis Symposium! Available from 07:00 BST 21st October

Treatment of Canine Otitis Externa: Challenges and Solutions for Clinical Practice

Just

one dose.

Dr. Ken Kwochka, Dip.ACVD. Sr. Dir. US Technical Marketing Elanco. President World Assoc. of Vet. Derm.

Ear cleaning

Diagnostics, Differentials, and Cytology

Dr. Linda Vogelnest BVSc (Hons), MANZCVS, FANZCVS (Dermatology) Specialist Veterinary Dermatologist, Associate Lecturer at the University of Sydney

Dr. James Noxon DVM Dip.ACVIM Morrill Professor in the Dept of Veterinary Clinical Sciences and Section Leader of the dermatology section at Iowa State University

Find out more

Use Medicines Responsibly

NeptraÂŽ is also known as Claroâ&#x201E;˘ in the United States & Canada. Neptra ear drops solution for dogs. One dose (1ml) contains 16.7 mg florfenicol, 16.7 mg terbinafine hydrochloride, equivalent to terbinafine base: 14.9 mg, and 2.2 mg mometasone furoate as active substances. Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Marketing authorisation holder in the EU: Bayer Animal Health GmbH, an Elanco Animal Health Company, Alfred-Nobel-Str. 50, 40789 Monheim am Rhein, Germany. All information presented is based on the European Summary of Product Characteristics (SPC). Registration conditions, including prescription status may vary from country to country - please contact your Elanco representative and check your registered local SPC/Product information for full information. PM-GLB-MAR-20-0641

MAKING LIFE BETTER FOR THEM, MAKES LIFE BETTER. Elanco welcomes Bayer Animal Health. Making life better means keeping pets safe and healthy. That’s why we’re coming together with Bayer Animal Health to make an even better Elanco. Together, we’re committed to providing a comprehensive suite of products along with unparalleled service and support to you, so you can do more for them.

EM-GLB-MAR-20-0068

Do not miss the MSD Vector Borne Disease Symposium VBD INTRO

PROF. FRANS JONGEJAN

HEARTWORM DR. HEATHER WALDEN

BABESIOSIS IN THE

DR. PETER J. IRWIN

DR. ANDREW LEISEWITZ

DEVELOPED WORLD

DEVELOPING WORLD

TICK-BORNE LEISHMANIOSIS PROF. GUADALUPE MIRÃ&#x201C;

BORRELIOSIS DR. KATHRYN REIF

RICKETTSIAL DISEASES

DR. SUSAN LITTLE

COMPLIANCE DR. ROBERT PHILIP LAVAN

WORLD CONGRESS OF VETERINARY DERMATOLOGY

MSD

SYMPOSIUM

Join us at the MSD booth Access our 8 VBD symposium talks Download free GIFs

Win a copy of our limited edition VBD book

Applies as a liquid. Forms as a gel. Active where it’s needed . 1

We’re all ears. When it comes to otitis externa*, Osurnia has real staying power. It has been designed so it is less likely to be dislodged from the ear. It’s easily administered, going in to the ear like a liquid, then forms as a gel, coating the ear lining and prolonging contact at the site of infection. A flexible, pre-measured, single-dose tube, means the dog gets the right dose every time, minimising discomfort. We hear you loud and clear.

Visit the Dechra WCVD booth to find out more *For the treatment of acute otitis externa and acute exacerbation of recurrent otitis externa associated with Staphylococcus pseudintermedius and Malassezia pachydermatis in dogs. Osurnia 1 dose (1.2 g) contains: Terbinafine: 10 mg, Florfenicol: 10 mg, Betamethasone acetate: 1mg equivalent to Betamethasone base 0.9 mg 1. Nuttal, T. and Forster, S. (2015) Terbinafine and florfenicol concentrations in the canine ear exceed minimum inhibitory concentrations for common otic pathogens after treatments with Osurnia® (Elanco Animal Health), In Proceedings of the British Veterinary Dermatology Study Group. Birmingham, UK; 2015; 91-94 Dechra Veterinary Products A/S, Mekuvej 9, 7171 Uldum, Denmark Dechra Veterinary Products A/S is a trading division of Dechra Pharmaceuticals PLC. www.dechra.com ©Dechra Veterinary Products A/S May 2020

Thank you to all of our event sponsors for making WCVD9 possible Find out more about all our sponsors here.

OUR SPEAKERS Meet our WCVD9 expert speakers!

MAIN CE SPEAKERS John Hutt BVSc(Hons) BA(Hons) MA(CW) CertVD MANZCVS DipACVD John H C Hutt graduated from the University of Queensland, Australia in 1988. He worked in general practice in his home city of Brisbane for 18 months before travelling to the UK in 1990, where he worked in small animal practice for the next 11 years. He was a clinical assistant in dermatology at the Animal Health Trust from 1998 to 2001. In 2001 John set up North Kent Referrals, a multi-disciplinary referral practice in the south of England, and he owned and ran the practice until its sale in 2012.John is a registered specialist in Veterinary Dermatology. He holds the RCVS Certificate in Veterinary Dermatology, is a member of the Australian College of Veterinary Scientists (MANZCVS) by examination in small animal medicine, and is a diplomate of the American College of Veterinary Dermatology. John is a past President of the British Veterinary Dermatology Study Group. Following his return to Brisbane in 2013, John joined the team at Dermatology for Animals. His clinical interests include the management of allergic skin disease in dogs, immune mediated skin disorders, and all aspects of feline and equine dermatology. John has regularly presented on the subject of veterinary dermatology to veterinary surgeons, nurses and technicians all over the world.Outside of work, Johnâ&#x20AC;&#x2122;s major interest is in English Literature and Creative Writing. He completed a Bachelor of Arts at the Open University in 2006, followed by an Honours year in Creative Writing in 2009. He completed a Master of Arts in Creative Writing in 2018.

#WCVD9

WCVD-9.COM

David Robson BVSc (Hons), MANZCVS (Canine Medicine), FANZCVS (Dermatology) Dr David Robson graduated from the University of Queensland with honours in 1992 and spent almost seven years in general small animal practice in Brisbane. He moved to Melbourne in late 1999 to commence his residency in veterinary dermatology at the Animal Skin, Ear and Allergy clinic (now Animal Skin and Ear Specialists and part of Melbourne Veterinary Specialist Centre) and never left. He attained Fellowship of the Australian and New Zealand College of Veterinary Scientists in 2005. Dr Robson has lectured in Australia and overseas (New Zealand, United States, Canada, Hong Kong, Austria) and has authored and co-authored multiple peer-reviewed scientific articles. His current professional research interests include methicillin-resistant Staphylococcus pseudintermedius, cyclosporin, and otitis diagnosis and treatment. In what spare time he has from work, house and family, he modifies and drives a small hatchback in time trials at the racetrack, takes a casual interest automotive aerodynamics, snowboards, plays guitar and bass (the latter in the dermatological supergroup The Yeasty Boys) and dives, though this latter not as often as he would like.

Mike Shipstone BVSc (Hons), MANZCVS, FANZCVS, DipACVD Mike graduated from The University of Queensland and worked in a number of different private practice and industry positions. He completed a residency in Melbourne, with Drs Ralf Mueller and Sonya Bettenay. He is principle and director of a specialist dermatology referral practice, based in Brisbane with satellite clinics in Darwin, Alice Springs, Newcastle, Cairns, Townsville, Mackay, Rockhampton and Bundaberg and is adjunct Professor at the University of Queensland, teaching the undergraduate course in Veterinary Dermatology.Mike is a Fellow of the Australian College of Veterinary Scientists (Veterinary Dermatology) and a Diplomate of the American College of Veterinary Dermatology. Mike has published in Australia and overseas and has presented in Australia, South East Asia, New Zealand and North America.

#WCVD9

WCVD-9.COM

Craig Griffin Dr. Craig Griffin is a graduate of Cornell University and completed his residency at UC Davis in 1980. Dr. Griffin is a Diplomate of the American College of Veterinary Dermatology (ACVD), has served on the Board of Directors and examination committee for the ACVD and was the President of the ACVD in 1999/2000. He also served as president of the American Academy of Veterinary Dermatology and of the Western States Veterinary Conference. Dr. Griffin is the founder and co-owner of Animal Dermatology Clinic. Dr. Griffin is a frequent lecturer and clinical instructor of veterinary dermatology in this country and abroad. He has published many articles and books on small animal skin disease, including co-author of Muller and Kirks Small Animal Dermatology 5th -7th editions and co editor of Current Veterinary Dermatology, The Science and Art of Therapy. Dr. Griffin received the ACVD Award for Excellence for outstanding contributions in veterinary dermatology in 2001-2014.

Wayne Rosenkrantz Wayne Rosenkrantz is a graduate of the University of California, Davis and completed his residency training in private practice. He is a past-President of the ACVD and is co-owner of the Animal Dermatology Clinics, with locations throughout California, southeast US, as well as Perth, Australia and Auckland, New Zealand. He actively trains residents in his ACVD approved residency training program and participates in clinical research trials. He has published many articles and book chapters on small animal and equine dermatology, including significant contributions to the text “Current Veterinary Dermatology: The Science and Art of Therapy” (Mosby) as well as the therapy section in the 7th edition of Muller and Kirk’s Small Animal Dermatology. He is also a co-editor of the text “Veterinary Allergy” (Wiley Blackwell). He is a recognized national and international speaker on veterinary dermatology. He was awarded the DVM Pharmaceutical Award of Excellence and the Frank Král award for his contributions to veterinary dermatology.

#WCVD9

WCVD-9.COM

Ralf Mueller Prof. Dr.med.vet. Ralf S. Mueller, DipACVD, FANZCVSc (Dermatology), DipECVD Prof. Ralf S. Mueller graduated in Munich/Germany, completed his doctoral thesis in 1987, and worked in several large and small animal practices before completing a residency in veterinary dermatology at the University of California/Davis in 1992. In 1992 he moved to Melbourne/Australia to work with his partner and wife Dr. Sonya Bettenay. Together, they created the first, purpose-built specialist practice in Australia. During that time, Dr. Mueller was concurrently consulting and teaching at the Veterinary Teaching Hospital/University of Sydney. Ralf and Sonya established (and continue to conduct) the Distance Education Program in Veterinary Dermatology of the Centre for Veterinary Education of the University of Sydney. In 1999, Ralf became Assistant Professor in Veterinary Dermatology at the College of Veterinary Medicine and Biomedical Sciences/Colorado State University. In 2004, he accepted a position as chief of the veterinary dermatology service at the University of Munich/Germany. His main research interests are allergies and ectoparasites. He has published over 250 studies, articles, book chapters and books and given more than twelve hundred seminars, lectures and talks all over the world.

#WCVD9

WCVD-9.COM

STATE OF THE ART CE SPEAKERS Dedee Murrell University of New South Wales Professor Dedee Murrell is Chair of the Department of Dermatology at St George Hospital, University of NSW, in Sydney, Australia. She completed medical training at Cambridge and Oxford Universities, 3 years of internal medicine in the UK and USA, dermatology training at UNC-Chapel Hill, a fellowship in dermatopharmacology at Duke, blistering diseases and cell biology at New York University, and then became a clinical scholar at Rockefeller University, focussing on epidermolysis bullosa. She holds a doctorate on the pathogenesis of blistering disorders, her main subspecialty interest, and her current research focusses on the development and validation of clinical outcome measures for EB and the Autoimmune blistering diseases to enable clinical trials to proceed in these orphan diseases. She has 275 peer reviewed papers and has edited 6 books on blistering diseases, including the new textbook. She lectures at international congresses regularly and is a visiting professor in 5 continents. She was recently elected as the first International Board Member of the EADV, has served as Executive Vice President of the International Society of Dermatology from 201113 , as Chair of Communications for the ISD, 2013-17, and will be the Congress President of the ICD 2021, in Melbourne, Australia. She serves as founding Co-Editor of the International Journal of Women’s Dermatology, is an associate editor of the British Journal of Dermatology and serves on the editorial boards of JAMA Dermatology, International Journal of Dermatology, JEADV, Acta Dermatovenereologica and previously, the JAAD. She has trained over 50 international fellows and mentees in her department since 1996 from the USA, Canada, England, France, Germany, Netherlands, Colombia, India, Sri Lanka, Indonesia, Korea, China, the Philippines. She was elected an international honorary member of the American Dermatologic Association in 2008, and awarded a certificate of appreciation from the ILDS for her international educational and outreach work. She recently completed a three year term as the Chair of the AAD’s World Congress Task Force and is passionate about international collaboration. She is one of two Vice Presidents of Australia’s bid to host the 2023 World Congress of Dermatology in Sydney.

#WCVD9

WCVD-9.COM

Rod Sinclair Professor Rodney Sinclair is the Professor of Medicine (Dermatology) at the University of Melbourne and the Director of Dermatology at the Epworth Hospital and Director of Sinclair Dermatology. He is Past-President of the Australasian Society for Dermatology Research, the Australasian Hair and Wool Research Society and the Skin and Cancer Foundation of Victoria. He was Professor/Director of Dermatology at St Vincent’s Hospital from 2005-2012. Prof Sinclair is the co-author of the section on Dermatology in the Oxford Textbook of Medicine, and the sections on Hair Loss and Scalp Diseases in Rook’s Textbook of Dermatology and Hair Disorders in Bologna’s Textbook Dermatology. He was formerly lead author of Therapeutic Guidelines- Dermatology, Australia. In a research career spanning 20 years he has supervised over 20 post-graduate research students including 7 PhD graduates and conducted over 30 Phase I, Phase II and Phase II clinical trials and has co-authored over 500 research publications and book chapters including 25 this year to date. Sinclair dermatology offer a 2 year hair fellowship for specialist dermatologists who wish to gain sub-specialty expertise in the diagnosis and treatment of hair disorders and hair restoration surgery.

#WCVD9

WCVD-9.COM

Eliane Marti Universitat Bern Professor Dr. Eliane Marti graduated in Veterinary Medicine in 1989 at the Faculty of Veterinary Medicine of the University of Bern and completed a Research Doctorate on the genetic predisposition of equine allergic diseases at the Division of Immunogenetics of the Faculty of Veterinary Medicine of the University of Bern in 1991. After a stay at the Baker Institute, Cornell University, NY, USA and after working in a large animal practice, she went back to the Division of Immunogenetics for Post-doctorate research from 1992 to 1994. In 1995 she worked on equine genetics at the Animal Health Trust, Newmarket, England, with a Post-doctoral Research grant of the Swiss National Science Foundation. Between 1996 and 1998 she had a Post-doctoral research position at the Division of Immunogenetics, University of Berne, where she stayed until 2001 with a grant of the Hans-Sigrist Foundation of the University of Berne for completion of habilitation. In 2002 she got the venia docendi in Veterinary Immunology from the University of Berne and since 2002 she is Head of the Clinical Immunology Group, Department of Clinical Research-Veterinary Public Healthy, at the Vetsuisse Faculty of the University of Berne, since 2009 as Associate Professor. Her present research focuses on the immunopathogenesis of allergic diseases of horses, in particular of equine insect bite hypersensitivity and on ways to improve in vitro diagnosis and treatment of these diseases as well as development of a preventive allergen immunotherapy for Icelandic horses. She has written over 100 scientific publications in peerreviewed journals and tutored over 25 doctoral thesis and PhDs.

#WCVD9

WCVD-9.COM

Stephen Jane Monash University Professor Jane is the Head of Central Clinical School, Monash University and Director of Research for Alfred Hospital. He is also a member of the Clinical Haematology Service. Professor Jane has a range of research interests investigating both developmental and acquired disorders of the blood and skin in mouse models. At a basic level, this involves the study of gene transcription and at the World Congress, Professor Jane will be speaking on the genetics of cutaneous barrier function. He currently holds a number of NH and MRC and other competitive grants. He has published over 120 papers including articles in Science, Nature Medicine and Developmental Cell.

Susan Prescott University of Western Australia Prof. Susan L. Prescott MD, PhD, is a paediatrician, immunologist and internationally acclaimed physician scientist, well known for her cutting-edge research into the early environmental determinants of health and disease. At the global level, as the Founding Director of inVIVO Planetary Health, her work focuses on the interconnections between human health and planetary health â&#x20AC;&#x201C; promoting holistic value systems for both ecological and social justice. Locally in Western Australia, she is Director of the ORIGINS project, which examines how the environment influences all aspects of physical and mental health throughout life. She was the founding President of the DOHaD Society of ANZ, and previously served as a Director of the World Allergy Organization. Susan is also an artist and award-winning author of several books including The Allergy Epidemic, The Calling, Origins and gold medal winning book The Secret Life of Your Microbiome. At the World Congress, Susan will be speaking on early immune development and its role in allergy.

#WCVD9

WCVD-9.COM

Darren Trott University of Adelaide Professor Trott completed his veterinary degree at Murdoch University and worked in small animal practice for eight years. Following a PhD on intestinal spirochaetes, he completed a three year post-doc at the National Animal Disease Center in Ames,Iowa, USA. He then taught veterinary microbiology and antimicrobial chemotherapy at The University of Queensland for 10 years whilst conducting research on gastrointestinal diseases, microbial ecology and virulence/antimicrobial resistance in bacterial pathogens. In 2010, he joined The University of Adelaide School of Animal and Veterinary Sciences and his research areas have expanded to include antimicrobial resistance ecology, repurposing existing drug classes for development as new anti-infectives, and the effect of antimicrobials on the gut microbiome. He established and is the inaugural Director of the Australian Centre for Antimicrobial Resistance Ecology, working closely with Australiaâ&#x20AC;&#x2122;s major animal industries (both livestock and companion animal) in the areas of prudent antimicrobial use, antimicrobial stewardship and confirming/ensuring that rates of resistance in animal pathogens, zoonotic and commensal bacteria remain low by international standards. At the World Congress, Professor Trott will be speaking on antimicrobial resistance and the development of novel antibacterial therapies.

#WCVD9

WCVD-9.COM

SUPPORTING REVIEW SPEAKERS Monika Welle Universitat Bern Prof. Dr. Monika Welle studied veterinary medicine in Berlin and Munich, and graduated in 1986. Thereafter she worked on her thesis in the GSF Institute of Experimental Hematology. She spent 2 years as a practicing veterinarian before she joined the Institute for Animal Pathology in Berlin in 1990. In 1995, she moved to Bern in Switzerland where she gained exposure to veterinary dermatopathology, which since has become her passion. She holds the German certificate for veterinary pathology specialization and is a diplomate of the ECVP. Since 2004, she is head of the biopsy service in the Institute of Animal Pathology in Bern and is involved in diagnostic pathology, undergraduate and postgraduate teaching and research. She has been board member, vice president and president of the International Society of Veterinary Dermatopathology and is responsible for the histopathology exam in the ECVD exam committee. Her main research focus is the hair follicle and alopecic disorders as well as genodermatoses in dogs. She is author or coauthor of more than 130 publications and has been invited to more than 100 lectures and case presentations.

#WCVD9

WCVD-9.COM

Richard Squires Cook University Richard Squires leads the veterinary clinical sciences team at James Cook University in Townsville, northern Australia. Richard graduated as a veterinarian from Bristol University. After a short spell in general practice he obtained postgraduate clinical training at the Universities of Cambridge and Pennsylvania and research training at Glasgow. His PhD was awarded for research in which he sought a retroviral aetiology for canine lymphoma. He is a Diplomate of both the American and European Colleges of Veterinary Internal Medicine and he holds the Royal College of Veterinary Surgeonsâ&#x20AC;&#x2122; Diploma of Veterinary Radiology. Richard held faculty positions at the Universities of Liverpool, Pennsylvania, Wisconsin and at Massey University in New Zealand prior to taking up his current position in 2007. Throughout much of his career Richard has taught and assessed veterinary students in a clinical setting while providing referral clinical services in the broad discipline of canine and feline internal medicine. Most of his research has been on canine and feline infectious diseases. In addition, for five years in New Zealand, Richard taught and carried out research in veterinary virology. Richard is a member of the World Small Animal Veterinary Associationâ&#x20AC;&#x2122;s eight-member Scientific Advisory Committee and of its four-member Vaccination Guidelines Group.

#WCVD9

WCVD-9.COM

Elizabeth Mauldin University of Pennsylvania Elizabeth Mauldin is a Professor of Dermatopathology at the University of Pennsylvania School of Veterinary Medicine. After a brief time in general veterinary practice, she completed sequential residencies in both anatomic pathology (Cornell University) and clinical dermatology (University of Pennsylvania) and is board-certified by both the ACVP and ACVD. She has a dual appointment in PennVet since 2004 where she works both as an anatomic pathologist and clinical dermatologist. As the Head of the PennVet Laboratory of Pathology, she oversees a surgical pathology and dermatopathology service that interprets biopsies for clients across North America. Her research interests are focused on the spontaneous skin diseases of companion animals and more specifically on comparative genodermatoses. Her work with Peter Elias MD (University of San Francisco VA Hospital) has helped to understand the pathogenesis of skin barrier dysfunction in dogs and humans with congenital ichthyosis.

Tetsuro Kobayashi NIH laboratory Tetsuro Kobayashi, DVM/PhD is an investigator at the Laboratory for Innate Immune Systems, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. His research focuses on crosstalk between epithelial cells, immune cells and microbiota in skin. He has investigated mechanisms by which epithelial homeostasis and microbiome balance is tuned by immune cells in steady state and how imbalanced microbiota leads to skin diseases, particularly atopic dermatitis. He currently extends his research area of focus to understand coordinated actions of epithelial cells and immune cells in chronic itch of atopic dermatitis. He graduated from Tokyo University of Agriculture and Technology and joined the Department of Dermatology at Keio University School of Medicine for a Ph.D. program where he investigated hair follicle stem cell biology. He did postdoctoral training in Dr. Keisuke Nagaoâ&#x20AC;&#x2122;s laboratory at Keio University School of Medicine and at Dermatology Branch, NIH.

#WCVD9

WCVD-9.COM

Although WCVD9 is online, that doesn't mean that you can't enjoy a great exhibition! You can explore the exhibition hall at your leisure and access loads of great interactive content from all of the exhibitors.

Let's explore the booths! #WCVD9

WCVD-9.COM

BOEHRINGER INGELHEIM

CEVA

#WCVD9

WCVD-9.COM

DECHRA

DERMCARE

#WCVD9

WCVD-9.COM

DERMOSCENT

ELANCO

#WCVD9

WCVD-9.COM

HILL'S PET NUTRITION

IDEXX

#WCVD9

WCVD-9.COM

LABOKLIN

LINKYVET

#WCVD9

WCVD-9.COM

MSD

PURINA INSTITUTE

#WCVD9

WCVD-9.COM

ROYAL CANIN

STALLERGENES GREER

#WCVD9

WCVD-9.COM

THE WEBINAR VET

TROY LABORATORIES

#WCVD9

WCVD-9.COM

VIRBAC

WAVD

#WCVD9

WCVD-9.COM

ZOETIS

We can't wait for you to explore the digital exhibition! #WCVD9

WCVD-9.COM

PRESENTATION REVIEWS with David Grant

MBE, BVetMed, CertSAD, FRCVS, Itâ&#x20AC;&#x2122;s a bit of a shock to be reminded that this will be the 9th WCVD congress. A shock, because I am fortunate to be old enough to have attended the first one in Dijon, France in 1989 - can it really be 29 years ago? The congress will live long in the memories of those that attended for its groundbreaking scientific and social programmes. For those new to veterinary dermatology you will find that veterinary dermatologists are amongst the best colleagues you will ever come into contact with. From that era we remember many great friends such as Peter Ihrke and Didier Carlotti, both sadly no longer with us. They were extroverts, true world experts and full of enthusiasm. The first world congress brought me into contact with dermatologists I only knew from articles and I made many lifelong friends. World veterinary dermatology is now a huge family of friends brought together by their special interest, of course, but also by personal contact at meetings and congresses.

Hans Koch, Didier Carlotti, Dominic Heripret, Lluis Ferrer and a host of other European specialists - too many to mention, so apologies to those left out! What they had in common was drive, enthusiasm, joie de vie, huge amounts of knowledge and without exception dominance of our language, (I have heard all those mentioned lecture in English). How insular I used to be! I have to mention also our own David Lloyd because he made many of the initial contacts with our European friends, and expanded this worldwide, which is when WCVD took on the mantle of expanding veterinary dermatology to every single part of the globe.

The European Society of Veterinary Dermatology (ESVD) congresses had already contributed to the internationalism of the discipline and without them I would never have met

PRESENTATION REVIEWS

Many of the ESVD visionaries were also important in the development of WCVD, and ensuring that successive congresses were always going to be in the most attractive parts of the world, showing great foresight. Many of us have, as a result, visited cities and countries that we may have overlooked otherwise. If you had been to all 8 WCVD congresses you would have spent some very pleasant days in Dijon, Montreal, Edinburgh, San Francisco, Bordeaux, Vienna, Hong Kong and Vancouver.

WCVD-9.COM

As a result of the coronavirus pandemic WCVD9 2020 in Sydney cannot take place live. This must have been a terrible disappointment to our Australian hosts, particularly as Sydney is one of the truly great world cities. But out of adversity comes a challenge and the WCVD committee has risen to the challenge by ensuring that the entire scientific programme will be available online via The Webinar Vet. And what a programme! For a fraction of the costs involved in attending the congress in Australia it will be possible to view all the lectures as webinars, and these will be available to view in the comfort of your home for six months. This is a one-off opportunity in all probability, and I know from personal experience that I did not access all the possible content in previous congresses, even with a proceedings book. Now with a little discipline it will be possible to watch more than 100 lectures delivered by the worldâ&#x20AC;&#x2122;s experts if you buy the full programme ticket. I have taken a look at this yearâ&#x20AC;&#x2122;s programme, it certainly looks superb. A very important point to make to colleagues new to dermatology, or just wondering how to get to grips with the subject, is that from the very beginnings it was always envisaged that there would be a major theme devoted to a general update for practitioners. This year is no exception and I am summarising here what to expect of the 2020 general update:

PRESENTATION REVIEWS

Diagnostic approach to the itchy dog without over-servicing - Ralf Mueller Ralf is Professor in dermatology at the vet school in Munich and has travelled widely in his career including a residency in UC Davis, faculty position in Colorado, a lengthy spell in Australia before returning to Germany. He is a diplomate of both the American and European colleges of Dermatology. He has been given a very interesting topic here, part of a very refreshing programme concentrating on subjects you may have chosen yourself. He is kept busy at this congress and I am very intrigued to know how he will deal with his second contribution

Parasitic skin diseases in the age of the isoxazolines - Ralf Mueller Will they exist?! This is a very relevant question. And following onâ&#x20AC;Ś

Demodicosis -is it still a problem? Ralf Mueller You have to guess that at least in the Munich area it is still a problem. The reasons why will no doubt become apparent. On a different topic he will be speaking about food and the skin.

Food and the skin- choosing the right diet. - Ralf Mueller I imagine this will be mainly to do with food allergy because he has published extensively on this along with much else.

WCVD-9.COM

Bound to be very useful update. Ralf’s final lecture in the general practice theme is more challenging (for him to get everything in, not for you. Enjoy the end product of a lot of thorough research).

And to add a bit of controversy…

Allergen specific immunotherapy: Does it still have a role? - Doug DeBoer Well, I wonder? Bearing in mind this presentation, along with all the others in this theme, is very much with the general practitioner in mind. It will be very interesting to hear what he makes of this subject. And in the advanced section (check the programme on the WCVD website), he tackles the subject from a different perspective, i.e. is it worth doing allergy tests?

Skin diseases of the muzzle and nasal planum - Ralf Mueller This will be a useful reference point the next time you encounter lesions in this area. There are many! The general practitioner update section is full of great speakers and the next one on my list is Doug DeBoer. No, he isn’t Dutch, he is from the USA and he has been delivering world-class talks for many years. He graduated from UC Davis in 1981, nearly 40 years ago. Like many academic veterinary dermatologists he didn’t take long to see the light and chose skin diseases as his specialty. Just 6 years later he was awarded diplomate status of the American College of Veterinary Dermatology. He teaches in the University of Wisconsin, Madison where he is the Professor of Veterinary Dermatology.

Atopic dermatitis is a very large component of a clinician’s caseload whether it is at first opinion or specialist level. At this congress the disease gets a comprehensive outing. There is no one better to start us off on this journey than Peter Hill. He has an extraordinary CV. He is a UK veterinary graduate and spent 5 years in practice, 3 years in a dermatology residency at MadisonWisconsin, a PhD at Edinburgh and has taught at Edinburgh, Bristol and since 2010 at the veterinary school of the University of Adelaide, where is associate professor.

Staph pyoderma – an update on diagnosis and management - Doug DeBoer

He has diplomate status in the UK (DVD), in addition to DACVD and DECVD. This combination of academic qualifications is unique worldwide, and his ability as a teacher has been recognised in the USA, the UK and Australia.

This is one of the most problematical skin disorders that we encounter almost from day one in practice. How to recognise it, establish the inevitable underlying factors, which antibiotic or will topical be just as good? It will all be there and more I am sure.

PRESENTATION REVIEWS

WCVD-9.COM

Clinical Signs and Diagnosis of Atopic Dermatitis - Peter Hill This will be the most comprehensive update and essential to enable you to get to grips with this common problem, and to follow up with the detail on pathogenesis to be found on the advanced practitioner component of the congress. But first a couple of presentations as a sequel. The first one is by Wayne Rosenkrantz. He is another graduate of UC Davis and has been board certified in veterinary dermatology since 1983. He is also a connoisseur of red wines, but you will need to see his extensive CV to find out why. His lectures are always fun and very informative.

Canine Atopic Dermatitis - where do the new treatments fit in? - Wayne Rosencrantz Along with the above two presentations, the one I have already mentioned by Doug DeBoer will be a perfect introduction to atopic dermatitis and for the advanced information on pathogenesis. But first there is an ever increasingly important aspect to the treatment of atopic dermatitis, topical therapy.

Topical Treatment of Atopic Dermatitis - Meng Siak Meng is a 2006 graduate from Murdoch Veterinary School. He spent a year in private practice before returning to Perth to train as a veterinary dermatologist, working exclusively in two referral dermatology clinics, as an intern and subsequently a resident.

PRESENTATION REVIEWS

In 2014 he passed the examinations and gained specialist status in veterinary dermatology as a Fellow of the Australian and New Zealand College of Veterinary Scientists (FANZCVS). He has a particular interest in allergic and immunemediated diseases. He is also a fan of Tottenham Hotspur football club, which will endear him to some colleagues I could mention. The general clinical update continues with an in depth consideration of another familiar common problemotitis externa. It wasn’t so long ago when most cases of otitis externa ended up with the surgeons, leading many of them to state ‘There is no medical treatment for otitis externa!’ Times have changed dramatically and I know that referrals often come from the surgeons these days. There are four presentations on otitis externa. We begin with a summary by Craig Griffin of the pathogenesis:

Pathogenesis of otitis externa - Craig Griffin Craig is a graduate at Cornell University and completed his residency at UC Davis in 1980-forty years as a specialist! As you might expect he has a very impressive CV including being one of the co-authors of Muller and Kirk’s Small Animal Dermatology 5th -7th editions. He has been in private veterinary practice in San Diego, predominantly, for many years. His presentations are always meticulously researched and you can be sure will be right up to date.

WCVD-9.COM

With this information fresh in your mind you will want to move on to the clinical aspects.

Monika studied veterinary medicine in Berlin and Munich, graduated in 1986 and practiced in Germany before joining the institute for Animal Pathology, Berlin in 1990. A move to Bern, Switzerland in 1995 stimulated her interest in dermatohistopathology, which has since become her passion. She is a diplomate of the ECVP.

Diagnostic approach to otitis externa - Peter Hill Peter gets a couple of shots at this problem but first a presentation on how to diagnose otitis externa, no doubt looking at the underlying factors in particular. And then Peter and Craig combine to look at the management of the condition, both in its acute and chronic forms.

Histopathologists are an essential part of the diagnostic team and this is sure to be a great introduction to alopecia. On the folliculitis aspect there is an update on dermatophytosis by Debbie Simpson.

Management of acute otitis externa - Peter Hill A very important contribution this, as it should prevent the condition becoming chronic. But if it does:

Dermatophytosis – update on diagnosis and management - Debbie Simpson

Management of chronic otitis externa and media - Peter Hill

Another theme is comprehensively tackled. This is alopecia and the first in this series is the diagnostic approach.

Debbie is a 2008 graduate from Massey University, New Zealand. She undertook specialist training in a Melbourne referral practice and Cornell University. This culminated in passing the examinations for Fellowship of the Australian and New Zealand College of Veterinary Scientists. In 2016 she opened a specialist dermatology referral clinic back in New Zealand. In this lecture she follows Monika Welle’s introduction, describing folliculitis as seen in dermatophytosis.

General diagnostic approach to alopecia-folliculitis vs follicular arrest - Monika Welle

The next speakers deal with follicular arrest, both on a theme ‘What should we be doing?’

These are the cases that the surgeons would almost exclusively see in the past, but far less now. It will be interesting to hear what Peter says about the role of surgical procedures in chronic otitis externa and when to call the surgeons in.

Now we have an input from a European specialist in Dermatopathology.

PRESENTATION REVIEWS

WCVD-9.COM

Hypothyroidism-what should we be doing? - Catherine Outerbridge Catherine is a professor of medicine and epidemiology at UC Davis. A graduate of the Ontario Veterinary College, Guelph, she moved south and since 2000 has been on the staff of UC Davis. During this time she has accumulated two diploma board qualifications. She is a diplomate of the American College of Veterinary Internal Medicine (ACVIM) and diplomate of the American College of Veterinary Dermatology (ACVD). The same applies to the next speaker Richard Squires. The more I look into the CVs of the speakers at this congress the more amazed I am. Richard is a 1982 Bristol graduate and very quickly made up his mind about where he wanted his career to go. He has received post-graduate training in the Universities of Cambridge, Pennsylvania and Glasgow. He has diplomate status of the American and European Colleges of Veterinary Internal Medicine, a PhD, and somewhere along the line a DVR. He is also not shy of travelling having held faculty positions at the Universities of Liverpool, Pennsylvania, Wisconsin and Massey and since 2007 he is the lead of the veterinary clinical sciences team at James Cook University at Townsville, northern Australia.

Hyperadrenocorticism – what should we be doing? - Richard Squires

PRESENTATION REVIEWS

To complete this general update programme are three further presentations on diverse subjects. Verena Affolter is presenting on nodular disease. She is Professor of pathology, microbiology and immunology at UC Davis. She has a PhD and is a diplomate of the European College of Veterinary Pathology. If you are wondering about her name and where she is from she graduated from the University Of Bern, Switzerland and quickly set off on an academic career by achieving a doctorate thesis a few years later followed by pathology training at her alma mater, then in Cornell. Her PhD was obtained at UC Davis in 1999 and they haven’t let her go! Her professorial emphasis at UC Davis currently is dermatopathology and immunopathology-perfect qualifications for her talk.

General Diagnostic Approach to nodular disease-is it infectious, sterile or neoplastic? - Verena Affolter An interesting diversion from the usual presentations on the dermatologists’ favourite parasite (the flea), is to concentrate on what you can catch from them. Michael Lappin is up for this task

Update on Flea borne zoonoses-what you can catch at work - Michael Lappin Michael is a graduate from Oklahoma State University and did a couple of years in practice after an internship at the University of Georgia.

WCVD-9.COM

Returning to Georgia he completed a small animal internal medicine residency and a PhD in parasitology. He is currently professor of small animal veterinary internal medicine at Colorado State University. He has an immense work ethic and has received numerous awards for his teaching. One of his many interests is zoonoses of cats - so expect a thought provoking session.

It is possible just to register just for this component. Given that you have a total of six months to view and reflect on the content I think it makes a lot more sense to register for the entire programme. Having worked your way through the above lectures much of the advanced programme is perfectly accessible and so I recommend you take a look at this on the WCVD9 website.

I used to think, and still do, that it is impossible to investigate dermatological cases without a microscope and a dermatological pathologist. I soon added cytology to those two and courses on cytology have taken off in recent years and in this programme there is an introduction to the subject, which is sure to whet your appetite.

I will finish with a strong recommendation, if you treat companion animals, do not miss out on the Feline Stream. I am adding a list of what you can look forward to:

It is delivered by Kim Coyner, who graduated from Colorado State University College of Veterinary Medicine in 1994. Following the usual path of internship and residency at the University of Georgia she attained diplomate status of the ACVD in 2001 and since then has been in private dermatology referral practice in the Tacoma and Lacey areas of the southwest United States. She has authored numerous continuing education articles.

What does cytology actually tell me and how can I use it? - Kim Coyner That concludes my dip into the update programme for general practitioners.

PRESENTATION REVIEWS

General Diagnostic approach to pruritic skin disease in cat. - Danny Scott Allergy testing in cats-is it worth it? - Mandy Burrows Management of the pruritic cathave we moved way from prednisolone. - Wayne Rosenkrantz Pyoderma in cats - is it really a problem? - Danny Scott Dermatoses of the face, head and neck-how often is it food allergy? Linda Vogelnest The eosinophilic granuloma complex â&#x20AC;&#x201C; has anything changed? - Danny Scott Ventral alopecia, is it dermatological, behavioural or medical? - Danny Scott Dermatophytosis â&#x20AC;&#x201C; how best to treat?- Kim Coyner Pododermatitis in cats. - Danny Scott Nodular skin diseases in cats. Meng Siak Feline Cushings Disease. Catherine Outerbridge

WCVD-9.COM

This is a fantastic feline programme and you may have noticed that Danny Scott has figured prominently. He also has three contributions in the equine stream. Many thousands of vets worldwide have learned from Danny Scott. His CV is truly astonishing and a good summary of it can be found by checking the International Canine Health Awards Lifetime Achievement awarded to Danny at the Kennel Club in London in May 2018.

PRESENTATION REVIEWS

Of note is that he has delivered more than 500 presentations across the globe, apart from numerous publications, including co-authoring the standard veterinary dermatology text. He is certainly the most travelled of all the world’s veterinary dermatology experts. Why have I singled him out? It’s because like many I thought he had retired and I managed to hear his ‘farewell’ lecture in Birmingham a couple of years ago. This will probably be the last opportunity to hear one of the world’s great communicators in our profession.

WCVD-9.COM

OTHER NEWS What other upcoming events can you look forward to?

WVA VIRTUAL SEMINAR THURS 29TH OCTOBER 3PM - 5PM CET

The Impact of the Covid-19 Pandemic on the Veterinary Profession â&#x20AC;&#x201C; Ongoing Assessment REGISTER NOW

The World Veterinary Association has put together a 2 hour virtual seminar on the impact of Covid-19 on the veterinary profession, and it's completely free to watch. The event will be taking place Thursday 29th October 2020, 15:00 - 17:00 CET.

OTHER NEWS

If you would like to register, read the event schedule, find out who will be speaking and more, you can find everything you need to know by clicking the link below: bit.ly/wva-covid-seminar

WCVD-9.COM

WSAVA/FECAVA Congress Goes Hybrid for 2020 to Increase Access to the Learning on Offer The World Small Animal Veterinary Association (WSAVA) has announced that its 2020 World Congress, held in collaboration with the Federation of Companion Animal Veterinary Associations (FECAVA) and the Polish Small Animal Veterinary Association (PSAVA), now scheduled to take place in Warsaw, Poland from 21-24 March 2021, is to be a hybrid event.

available online for those for whom travel restrictions caused by the COVID-19 pandemic make getting to Poland difficult. The WSAVA, which represents more than 200,000 companion animal veterinarians globally, is making this move in order to ensure that as many of its members as possible can benefit from the unique learning opportunity on offer.

FIND OUT MORE

The Congress will go ahead for faceto-face delegates with the state-ofthe-art scientific program also

OTHER NEWS

WCVD-9.COM